Clinical Trials Logo

Labral Tear, Glenoid clinical trials

View clinical trials related to Labral Tear, Glenoid.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05974423 Enrolling by invitation - Opioid Use Clinical Trials

Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair

Start date: December 16, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if patients age 15 to 30 years old being treated for shoulder labrum repair and SLAP lesions have significant differences in pain levels postoperatively when treated with a combination therapy of ibuprofen, and acetaminophen compared to oxycodone. Participants will be randomly placed into either the control arm and receive scripts for non-narcotic medications (Tylenol and Ibuprofen) and opioids, or the experimental arm of the study. receiving only a prescription for the non-narcotic medications. Every patient will receive a preoperative Exparel nerve block as is the standard of care for this procedure. Both groups will fill out a pain journal for 14 days following surgery and complete a pill count at the first postoperative visit to validate the amount of pain medication documented in the pain journal.

NCT ID: NCT04278716 Enrolling by invitation - Clinical trials for Labral Tear, Glenoid

Return to Play Checklist

Start date: May 14, 2018
Phase:
Study type: Observational

This study will try to develop and determine objective and validated criteria for our athletes to safely return to sports after labral repair.